# Genetic Response to Warfarin in Healthy Subjects

> **NCT01520402** · NA · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 35 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT01520402
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520402, "Genetic Response to Warfarin in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01520402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*